BRITISH SOCIETY OF BLOOD AND MARROW TRANSPLANTATION AND CELLULAR THERAPY

Registered charity 1125795 · accounts filings on the Charity Commission register · also known as BRITISH SOCIETY OF BLOOD AND MARROW TRANSPLANTATION

To promote education and research in blood and marrow stem cell transplantation and cellular therapy in the UK and Republic of Ireland.

Objects

(A) TO ADVANCE HEALTH BY THE PROMOTION OF RESEARCH INTO AND THE ADVANCEMENT OF KNOWLEDGE OF THE USE OF ALLOGENEIC OR AUTOLOGOUS HAEMOPOIETIC STEM CELLS AND CELLULAR THERAPY IN THE TREATMENT OF LEUKAEMIA, LYMPHOMA, MYELOMA, AND OTHER MALIGNANT DISORDERS, NON-MALIGNANT HAEMATOLOGICAL DISORDERS INCLUDING APLASTIC ANAEMIA AND HAEMOGLOBINOPATHIES AND APPROPRIATE NON HAEMATOLOGICAL DISEASES;

Area of benefit: NATIONAL

The charity’s charitable objects and area of benefit, quoted from its governing document as held on the Charity Commission register.

Causes: The Advancement Of Health Or Saving Of Lives · website · Get email alerts

Registered contact address: Southwark, London, England (from the postcode on the register)

Latest income
£638k
Latest spending
£576k
Registered
2008
Accounts read
FY2025

Financial health, per its FY2025 accounts

The accounts state that the charity generated a net incoming resource of £61,847 for the year ended 31 December 2025, increasing its net assets to £539,680. However, the trustees report that free reserves were only £58,305, which is significantly below the stated policy target of £481,375. The trustees acknowledge that static income and rising costs have hindered the society's ability to expand, though they anticipate future growth through commercial partnerships.

Automated summary of the FY2025 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Reserves policy: four months of identified financial liabilities including redundancy costs, amounting to £481,375 (reserves figure: £58k)
“The Trustees have determined that the Society should maintain a minimum level of free reserves equivalent to four months of identified financial liabilities including redundancy costs, amounting to £481,375.” — page 14
Per its FY2025 accounts as filed with the Charity Commission.
Related-party transaction: Income from Anthony Nolan, a charity where trustee Dr V T Potter is also a trustee.
“During the year ended 31 December 2025 the charity received income of £45,558 (2024: £42,277) from another charity, Anthony Nolan, in which Dr V T Potter is also a trustee. As at 31 December 2025, £11,437 (2024: £11,246) was due to the charity from Anthony Nolan.” — page 31
Per its FY2025 accounts as filed with the Charity Commission.

Accounts independently examined (not a full audit). Discloses 5 of 6 completeness components.

Year-over-year changes

Comparing this charity’s FY2024 and FY2025 accounts as analysed by this site.

Policies the charity declares

In its annual return the charity told the Commission that it has the policies listed below. This is self-declared: it is not verified by the Commission or by this site, and it is not evidence of how a policy works in practice.

From the charity’s annual return (Part A, self-declared)

Answers and figures the charity gave in Part A of its annual return to the Charity Commission. They are self-declared: not verified by the Commission or by this site. Only positive answers and figures are listed; items not listed are simply not shown.

Self-declared on the annual return for the financial year ending 31/12/2025

  • Volunteers: 83
  • Government income: £224,263 — contracts £224,263 (1); 35% of the £637,663 total gross income on the same return

Self-declared on the annual return for the financial year ending 31/12/2024

  • Volunteers: 76
  • Government income: £200,362 — contracts £200,362 (2); 37% of the £540,723 total gross income on the same return

Self-declared on the annual return for the financial year ending 31/12/2023

  • Volunteers: 38
  • Government income: £192,200 — grants £192,200 (2); 49% of the £393,699 total gross income on the same return

Source: this charity’s annual returns on the Charity Commission register.

Structured financials (annual return, FY ending 31/12/2025)

Total income
£638k
Total spending
£576k
Reserves (reported)
£540k
Employees
0

Reported reserves equal ~11.2 months of spending — above the median for charities its size (median 5.2 months; benchmarks).

Per its annual return, largest income source: Other trading activities (99% of income) — components as reported reconcile to the return’s total income; not from the accounts narrative.

Per its annual return, cost of raising funds: 0.0% of total income — below the median for charities its size (4.9%) (benchmarks).

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: Northern Ireland · Scotland · Throughout England And Wales

Income and spending

Financial year endIncomeSpending
31/12/2025£638k£576k
31/12/2024£541k£533k
31/12/2023£394k£460k
31/12/2022£376k£425k
31/12/2021£342k£394k

Common questions

Is BRITISH SOCIETY OF BLOOD AND MARROW TRANSPLANTATION AND CELLULAR THERAPY financially healthy?

Per its FY2025 accounts: The accounts state that the charity generated a net incoming resource of £61,847 for the year ended 31 December 2025, increasing its net assets to £539,680. However, the trustees report that free reserves were only £58,305, which is significantly below the stated policy target of £481,375. The trustees acknowledge that static income and rising costs have hindered the society's ability to expand, though they anticipate future growth through commercial partnerships. Its FY2025 accounts were independently examined.

Funders of similar charities

Funders whose accounts show grants to charities similar to this one (and no recorded grant to this charity) — a starting list for fundraisers.

FunderSimilar charities fundedAmount to them
THE COMPANY OF BIOLOGISTS1£175k

Charities like this

Semantically similar by activities and financial character, from our analysed corpus. Compare with THE BRITISH BLOOD TRANSFUSION SOCIETY.

Side by side with its peers

CharityIncomeTop pay bandStaff >£60kReserves vs policyFundraising costGoing concern
BRITISH SOCIETY OF BLOOD AND MARROW TRANSPLANTATION AND CELLULAR THERAPY£638k—0unclear—no doubt
THE BRITISH BLOOD TRANSFUSION SOCIETY FY2026£281k——unclear—no doubt
THE BRITISH TRANSPLANTATION SOCIETY FY2025£774k—0above—no doubt
British Microcirculation and Vascular Biology Society FY2025£27k——unclear—no doubt
BRITISH SOCIETY OF ENDOVASCULAR THERAPY FY2026£364k—0above—no doubt
BRITISH SOCIETY FOR CELL BIOLOGY FY2025£138k—0unclear—no doubt

Each row is that charity’s latest analysed filing; every value is quote-backed on its own page.